A method for rapid multi-copy integration of target genes in bacterial chromosomes
By modifying the CRISPR-Cas-related transposal system, its crRNA targets genome multi-copy sequences or forms an array, combining solid plate scribe passages and sgRNA-induced transcription, the problem of multi-copy integration in bacterial chromosomes in the prior art is solved, and the problem of multi-copy integration in bacterial chromosomes is achieved Gene editing without legacy markers and fixed-points improves the copy number control accuracy of the gene expression cassette and is suitable for industrial applications.
Patent Information
- Application Number
- CN202010083919.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2020-02-10
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2040-02-10
AI Technical Summary
Existing genome multi-copy editing technology is difficult to achieve rapid, marker-free, site-directed multi-copy integration in bacterial chromosomes, and the types of commonly used plasmid replicates are limited, making it difficult to accurately control the expression dose of the gene expression cassette.
By modifying the INTEGRATE and CAST systems of the CRISPR-Cas-related transposal system, its crRNA targets genome multi-copy sequences or forms crRNA arrays, combining solid plate scribe passages and sgRNA-induced transcription, multi-copy insertion of target genes in bacterial chromosomes, Build the MUCICAT system to achieve legacy markers, site-directed, stable and efficient gene editing.
It realizes rapid, legacy marker-free, and fixed-point multi-copy integration in bacterial chromosomes, simplifies the gene editing process, improves the copy number control accuracy of the gene expression cassette, and is suitable for industrial applications.
Smart Images

Figure BDA0002381339140000091 
Figure BDA0002381339140000101 
Figure BDA0002381339140000102
Abstract
Description
Technical Field
[0001] The invention belongs to the field of genetic engineering and relates to a method for rapidly integrating a target gene into a bacterial chromosome in multiple copies, and a gene editing system for inserting a target gene into a bacterial chromosome in multiple copies. Background Art
[0002] Optimizing the expression dosage of the target gene expression cassette is an important step in constructing high-performance biocatalysts, but commonly used plasmids are prone to genetic instability, and due to the limited types of available plasmid replicons and the influence of multiple factors on the copy number, the expression dosage of the gene expression cassette is difficult to be accurately controlled (Tyo, et al., Stabilized gene duplication enables long-term selection-free heterologous pathway expression. Nature Biotechnology, 2009, 27 (8): 760-U115.). Although the gene editing technology of the important industrial chassis cell Escherichia coli is relatively mature, it takes at least 2 days for each round of operation to iteratively integrate the gene expression cassette into the chromosome, making it difficult to quickly obtain engineered bacteria containing a series of gene expression cassette copies (Jiang, Y., et al., Multigene editing in the Escherichia coli genome using the CRISPR-Cas9 system. Appl Environ Microbiol, 2015). Gregory laboratory in the United States has reported the method CIChE (Tyo, et al., ibid.) of high copy of chromosome gene cassette, based on the principle of homologous recombination, using the high copy tandem repeat gene expression cassette to be screened by promoting chloramphenicol concentration, but the disadvantage is that chloramphenicol resistance marker is left on the Escherichia coli chromosome to affect its industrial application. Mu replication transposition technology can theoretically realize high copy of gene expression cassette without using antibiotic marker, but the transposition position of gene expression cassette is random (Akhverdyan, VZ, et al., Application of the bacteriophage Mu-driven system for the integration / amplification of target genes in the chromosomes of engineered Gram-negative bacteria-mini review." Applied Microbiology and Biotechnology, 2011, 91 (4): 857-871.).
[0003] Although CRISPR-Cas can simultaneously cut multiple copies of genomic sequences or simultaneously target multiple different sequences with crRNA array, it is limited by the low repair efficiency of homologous recombination and it is difficult to insert more than three copies of gene expression cassettes at one time (Jiang, Y., et al., ibid.). Therefore, there is an urgent need for an editable, fast, non-marking, and site-specific chromosome multi-copy integration system to become a powerful tool for metabolic engineering and synthetic biology.
[0004] In 2019, Science and Nature respectively published two similar research results by Feng Zhang’s research group at the Broad Institute (Jonathan Strecker et al., RNA-guided DNA insertion with CRISPR-associated transposases. Science, 2019, 365, 48-53) and Sam Sternberg’s research group at Columbia University (Sanne E. Klompe1, et al., Transposon-encoded CRISPR–Cas systems direct RNA-guided DNA integration. Nature, 2019, Vol. 571, https: / / doi.org / 10.1038 / s41586-019-1323-z.): using bacterial transposase genes to precisely insert DNA sequences into the genome without cutting DNA. Feng Zhang’s research group extracted a transposase from cyanobacteria, which they named CAST, or CRISPR-associated transposase. After discovering a unique "transposable gene" (transposon) in Vibrio cholerae, Sternberg's research group developed a gene editing tool called INTEGRATE (Insertion of transposable elements by guide RNA-assisted targeting), which can insert large gene fragments into the genome without introducing DNA breaks. The new technology INTEGRATE uses transposable genes to insert DNA sequences into the genome without cutting the DNA. These two studies reported that the CRISPR-Cas related transposition system CAST system and INTEGRATE system can integrate DNA fragments into preset sites on the Escherichia coli chromosome through transposition without relying on homologous recombination, without resistance marker residues and double-stranded DNA breaks. However, the above methods are limited to insertion at a single site in the genome, and it is not possible to insert multiple copies of the target gene cassette into the chromosome. Summary of the invention
[0005] To overcome the above-mentioned defects of existing genome multi-copy editing technologies, we conducted in-depth research on the CAST system and the INTEGRATE system, and speculated that by designing crRNA sequences or crRNA arrays targeting multiple sites on chromosomes, it is possible to use the CRISPR-Cas related transposition system to achieve multi-copy insertion of the target gene cassette into the chromosome. Based on the comparison and combination of these two CRISPR-related transposition systems, we developed an editable, mark-free, site-specific, rapid and efficient method for multi-copy bacterial chromosome target genes (abbreviated as MUCICAT), which was verified by the following strategies: 1. Replace the single crRNA in the INTEGRATE system or CAST system that can only target a single site with a crRNA targeting a multi-copy sequence of the genome (i.e., a multi-copy DNA sequence in the genome, referred to as "multi-copy sequence") or a crRNA array (crRNAarray) composed of different crRNAs; 2. Extend the transposition time by streaking on solid plates, and the number of inserted copies increases with the increase in transposition time, so that a strain library containing genes with a series of copy numbers on the chromosome can be obtained; 3. Construct a plasmid pCutamp containing Cas9 and sgRNA targeting the common sequence of the INTEGRATE and CAST system tool plasmids, transform it into the above-mentioned library strain, induce transcription of sgRNA with rhamnose, and eliminate the transposition tool plasmid. The pCutamp plasmid contains the sacB gene. By eliminating the plasmid pCutamp on a sucrose plate, an engineered strain with multiple copies of the genomic target gene without a plasmid can be obtained.
[0006] Therefore, the first object of the present invention is to provide a method for integrating multiple copies of a target gene into a bacterial chromosome, comprising the following technical solutions:
[0007] A method for rapid multi-copy integration of a target gene in a bacterial chromosome comprises the following steps: for a CRISPR-Cas related transposition system INTEGRATE system or CAST system, modifying the crRNA sequence targeting a single genomic site in its crRNA expression plasmid, so that the modified crRNA targets multiple sites in the bacterial chromosome, guides the insertion of the target gene into these sites, and realizes multi-copy insertion of the target gene on the bacterial chromosome.
[0008] The above-mentioned modified crRNA can target multi-copy sequences in the genome, that is, the modified crRNA sequence is a partial sequence of the multi-copy sequence on the bacterial genome; or form two or more crRNA arrays that target different sites in the bacterial chromosome, respectively, and the crRNA array is composed of more than two crRNAs, that is, the modified crRNA sequence is a crRNA array composed of partial sequences of multiple different sites in the genome.
[0009] The above-mentioned modified crRNA or crRNA array can be cloned in the V-type CRISPR nuclease expression plasmid pQCascade_entry (abbreviated as pQCascade) in the INTEGRATE system, or cloned in the pHelper_ShCAST_sgRNA (abbreviated as pHelper) in the CAST system for expression; it can also be expressed by a separate vector.
[0010] When the transformed crRNA is expressed by pQCascade in the INTEGRATE system or pHelper in the CAST system, the plasmid pQCascade or pHelper, the target gene (cargo) expression vector pDonor in the INTEGRATE system or the CAST system, and the transposase expression vector pTnsABC in the INTEGRATE system are transferred into bacterial competent cells and screened. The above-mentioned transformed plasmids pHelper and pDonor constitute a two-plasmid system for the MUCICAT of the present invention; or the transformed plasmids pQCascade, pDonor and pTnsABC constitute a three-plasmid system for the MUCICAT of the present invention.
[0011] Preferably, the above bacteria include but are not limited to Escherichia coli, which may be K-12, B and W strains of Escherichia coli, such as Escherichia coli BL21 (DE3) or MG1655 (DE3).
[0012] In one embodiment of MUCICAT, pDonor and pTnsABC in the INTEGRATE system are first transformed into bacteria and screened on LB solid plates containing antibiotics such as ampicillin and / or kanamycin; then positive clones are selected and prepared into electroporated competent cells, and the pQCascade plasmid is transformed into the competent cells, which are then screened on LB solid plates containing antibiotics such as ampicillin and / or kanamycin and / or streptomycin; the screened clones are subjected to copy number verification by colony PCR to obtain gene-edited strains containing genes with different copy numbers on the chromosome.
[0013] Furthermore, the above clones may be subjected to plasmid elimination, for example, using the plasmid pCutamp constructed by the present invention to eliminate the plasmid of the above clones to obtain a plasmid-free gene-edited strain, comprising the following steps:
[0014] 1) The clones screened above were prepared into electroporation competent cells, and the electroporated plasmid pCutamp was cultured overnight on a LB solid plate containing apramycin and rhamnose, wherein rhamnose induced the transcription of sgRNA and eliminated the transposition tool plasmid;
[0015] 2) The positive clones obtained on the plate in step 1) were respectively spotted onto single antibiotic LB solid plates containing ampicillin, kanamycin or streptomycin, and simultaneously spotted onto LB solid plates containing 10 g / L sucrose to screen out the plasmid pCutamp itself (because the pCutamp plasmid contains the sacB gene, it was screened out on the sucrose plate to eliminate itself);
[0016] 3) Select the clones that cannot grow on the single antibiotic LB solid plate of ampicillin, kanamycin or streptomycin in step 2) but grow on the sucrose plate, spot them on the apramycin plate, verify the elimination of the pCutamp plasmid, and obtain the edited strains that have eliminated all plasmids.
[0017] Among them, the above-mentioned pCutamp plasmid contains a sgRNA gene targeting the common sequence of the AmpR promoter on the three plasmid backbones of pQCascade or pHelper, INTEGRATE system pDonor and pTnsABC.
[0018] The second object of the present invention is to provide a new gene editing system, which can be called a "multi-copy insertion system", which can be referred to as the MUCICAT system herein, and includes: the V-type CRISPR nuclease expression plasmid pQCascade in the INTEGRATE system, or pHelper in the CAST system, on which the above-mentioned modified crRNA or crRNA array is cloned; the plasmid pDonor in the INTEGRATE system or the CAST system, which contains the target gene cargo; the transposase expression vector pTnsABC in the INTEGRATE system. The above-mentioned plasmid pQCascade or pHelper, plasmid pDonor and plasmid pTnsABC constitute a three-plasmid system for multi-copy insertion of the target gene (cargo) in the bacterial chromosome.
[0019] The above-mentioned pQCascade contains the cas5678 nuclease gene and tniQ gene derived from Vibrio cholerae, a crRNA array, a CloDF13 replicon, a T7 promoter, a lacI repressor protein gene, and a streptomycin resistance gene.
[0020] The pHelper plasmid contains the cas12k nuclease gene from Bifidobacterium hallii, tnsBC, tniQ transposase gene, crRNA array, pBR322 replicon, J23119 constitutive promoter, and ampicillin resistance gene.
[0021] In one embodiment, one crRNA in the crRNA array targets the IS186 sequence in the chromosome of bacteria such as Escherichia coli, and the spacer sequence may be: 5'-TGGATGCTTTGCGTGCAAAGGAACCTGAACTC-3' (SEQ ID NO: 1). In this case, the pQCascade plasmid may be represented as pQCascade-IS186.
[0022] In another embodiment, one crRNA in the crRNA array targets the IS1 sequence in the chromosome of bacteria such as Escherichia coli, and the spacer sequence can be: 5'-TGGCACGGCTGGGACGGAAGTCGCTGTCGTTC-3' (SEQ ID NO: 2). In this case, the pQCascade plasmid can be represented as pQCascade-IS1.
[0023] In one embodiment, the sequence of the crRNA array may be SEQ ID NO: 3:
[0024] CCATGGGTGAACTGCCGAGTAGGTAGCTGATAACGCCTGGCTTGGCGATGCTCGCCTGATCGACAAGTGAACTGCCGAGTAGGTAGCTGATAACGAGAATATTGTGGCAAAAGCGCATAAGGTGCTGTGAA CTGCCGAGTAGGTAGCTGATAACGTCAGAGTGGCGTATCCGATGAATCACCACAGGTGAACTGCCGAGTAGGTAGCTGATAACGCAGAAGTGCACGGCGTGTGCGGCGGCGAGCAGTGAACTGCCGAGTAGG TAGCTGATAACTCGATCCGTGGGTGTTTATGTTCTCAGCAGGAGTGAACTGCCGAGTAGGTAGCTGATAACTTACTTACGGCGTTGCGCATTCTCATTGCACCGTGAACTGCCGAGTAGGTAGCTGATAAC GCATTACTAAGCTGGCGCGTGAAGCTGTAGAAGTGAACTGCCGAGTAGGTAGCTGATAACGGGGCGTAAAAAGAAGGGGCGCTGATTAACGCGTGAACTGCCGAGTAGGTAGCTGATAACGGATCC(SEQID NO:3).
[0025] The above plasmid pDonor contains LE and RE sequences for transposition, the target gene (cargo) and the pMB1* replicon.
[0026] The pTnsABC comprises the transposase encoding gene tnsABC derived from Vibrio cholerae, a T7 promoter and a ColA replicon.
[0027] The plasmid pQCascade or pHelper for expressing the crRNA array of the present invention may include pQCascade-IS1, pQCascade-IS186, pQCascade-array1, pT7-Helper-IS1 and pHelper-array2, wherein the pQCascade-IS1 plasmid comprises a spacer sequence targeting 28 copies of the IS1 sequence of the BL21 (DE3) genome; the pQCascade-IS186 plasmid comprises a spacer sequence targeting 5 copies of the IS186 sequence of the BL21 (DE3) genome; the pQCascade-array1 comprises an array1 sequence consisting of 9 direct repeat sequences and 8 spacers targeting different sites of the BL21 (DE3) genome; the pT7-Helper-IS1 plasmid comprises a spacer sequence targeting 29 copies of the IS1 sequence of the BL21 (DE3) genome; and the pHelper-array2 comprises an array2 sequence consisting of 9 direct repeat sequences and 8 spacers targeting different sites of the BL21 (DE3) genome.
[0028] In a preferred embodiment, the gene editing system further comprises a plasmid pCutamp for eliminating plasmids pQCascade or pHelper, pDonor and pTnsABC, thereby making the MUCICAT system a four-plasmid system.
[0029] The plasmid pCutamp contains cas9 gene, sacB gene and sgRNA. Preferably, the modified sgRNA is a sgRNA gene targeting the common sequence of the AmpR promoter on the three plasmid backbones.
[0030] In one embodiment, the crRNA can target the IS1 sequence in the chromosome of bacteria such as Escherichia coli, and the spacer sequence can be: 5'-TTTTATGTTCAGATAATGCCCGAT-3' (SEQ ID NO: 4). In this case, the pHelper plasmid can be a derivative plasmid pT7-Helper, represented as pT7-Helper-IS1.
[0031] Preferably, when used in conjunction with the pHelper series plasmids, the auxiliary plasmid pDonor can be the plasmid pDonor-kanR in the CAST system or the derivative plasmid pSC101-Donor.
[0032] In one embodiment, the gene editing system can be provided in the form of a kit, which includes plasmids pQCascade or pHelper, pDonor, pTnsABC, pCutamp, and various PCR primers for implementing genome editing.
[0033] As a specific application example of the gene editing system of the present invention, it can be used, for example, to construct a glucose dehydrogenase (GDH) production strain, etc.
[0034] The MUCICAT system of the present invention can quickly and editably insert multiple copies of the target gene into the expected site in the bacterial genome, achieving no residual markers, fixed-site, stable and efficient gene editing. Using this system, a bacterial library containing different copies of the target gene can be quickly generated, which has broad industrial application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0035] Figure 1 This is a gel electrophoresis diagram for detecting the amount of gene insertion copies targeting the IS186 site of the E. coli BL21 (DE3) genome. The band numbers 1-5 refer to the 1-5 sites of the insertion sequence IS186 on the genome, and M is Mark.
[0036] Figure 2 It is a bar graph showing the changes in the number of IS1 sites inserted into each strain during the transposition passage process in Example 1.
[0037] Figure 3 This is a schematic diagram of the gene insertion at the IS1 site of strain IS1Cm-16A in Example 1.
[0038] Figure 4 This is a gel electrophoresis diagram of detecting the number of inserted copies at 8 different sites of the E. coli BL21 (DE3) genome during the passage process. The band numbers 1-8 refer to sites 1-8 on the genome, and M is Mark.
[0039] Figure 5 It is a bar graph showing the changes in the number of insertion sites at the 8 genomic sites during the subculture process in Example 2.
[0040] Figure 6 It is a schematic diagram of the structure of the plasmid pCutamp constructed by the present invention.
[0041] Figure 7It is a comparison chart of the GDH enzyme activity of the strain T7-GDH with different genome copies constructed by the present invention and the plasmid version strain (pET24a-GDH).
[0042] Figure 8 This is a gel electrophoresis diagram of the target gene inserted into 29 IS1 sites of the E. coli BL21 (DE3) genome in Example 4. The band numbers 1-30 refer to sites 1-29 on the genome, respectively, and M is Mark. DETAILED DESCRIPTION
[0043] The present invention is a new CRISPR-Cas related transposition system formed by modifying and combining the two CRISPR related transposition systems of the prior art, the CAST system and the INTEGRATE system, so as to achieve multi-copy insertion of a target gene (cargo) into a bacterial chromosome.
[0044] The existing INTEGRATE system includes three plasmids: pQCascade, pDonor and pTnsABC, among which pQCascade contains the cas678 nuclease gene and tniQ gene.
[0045] The existing CAST system includes two plasmids: pHelper (containing cas and transposase) and pDonor. pHelper contains tnsBC, tniQ, Cas12k, tracrRNA, and spacer genes.
[0046] The pDonor in the existing INTEGRATE system contains RE, LE, and target gene cargo.
[0047] The pDonor in the existing CAST system contains RE, LE, target gene cargo, and kanamycin resistance gene kanR.
[0048] The present invention focuses on transforming the original crRNA in the INTEGRATE system and the CAST system, increasing the genomic sites that can be targeted, thereby forming a new genome editing tool MUCICAT. In order to reflect the difference between the original crRNA sequences in the INTEGRATE system and the CAST system of the present invention and the prior art, the crRNA used in the MUCICAT system of the present invention can be referred to as "transformed crRNA". The transformed crRNA is also a base pairing sequence designed according to the target sequence expected to be directed edited on the genome, as a crRNA array, to guide the insertion of the target gene into a multi-copy sequence in the genome, or into a plurality of different sites in the genome.
[0049] The modified crRNA can be a crRNA sequence targeting a multi-copy sequence in the genome, which is a partial sequence of a multi-copy sequence on the bacterial genome; or it can be a crRNA array composed of two or more crRNAs, each targeting different sites in the bacterial chromosome.
[0050] The term "multi-copy sequence" may also be referred to as a "repeated sequence", which is a sequence that exists in multiple copies in the genome.
[0051] In this article, for the sake of simplicity of description, a certain protein such as nuclease Cas is sometimes mixed with the name of its encoding gene (DNA), and those skilled in the art should understand that they represent different substances in different description occasions. Those skilled in the art can easily understand their meanings based on the context and context. For example, for Cas, when used to describe the function or category of nuclease, it refers to protein; when described as a gene, it refers to the gene encoding the Cas. Similarly, RNA such as sgRNA or crRNA is sometimes mixed with the name of its encoding gene (DNA), and those skilled in the art should understand that they represent different substances in different description occasions.
[0052] When using the MUCICAT system of the present invention to perform gene editing on bacteria, taking Escherichia coli BL21 (DE3) as an example, the following steps may be included:
[0053] 1) pDonor and pTnsABC were electroporated into BL21(DE3) and screened on LB solid plates containing ampicillin and kanamycin at 37°C.
[0054] 2) Select positive clones, prepare them into electroporation competent cells, and then electroporate pQCascade-array1 into the above bacteria. Screen them on LB solid plates containing ampicillin, kanamycin and streptomycin at 37°C.
[0055] 3) Scrape a portion of the clones on the plate in step 2) and resuspend them in liquid LB medium, and re-spread them on a solid LB plate supplemented with a final concentration of 0.1 mM IPTG, ampicillin, kanamycin, and streptomycin. IPTG is responsible for inducing the expression of transposition-related enzymes. Culture at 37°C for 16 hours.
[0056] 4) Scrape a portion of the clones on the plate in step 3) and resuspend them in liquid LB medium. Adjust the OD 600 After the concentration reaches about 0.5, dilute 50 times, and apply 100 μL on a solid LB plate supplemented with 1 mM IPTG, ampicillin, kanamycin, and streptomycin. IPTG is responsible for inducing the expression of transposition-related enzymes. Culture at 37°C for 24 hours.
[0057] 5) To increase the number of inserted copies, you can choose to extend the transposition time by subculturing. Use a 10μL pipette tip to dip the positive clone grown on the plate in step 4), spot it on a new LB solid plate containing 1mM IPTG and the above three antibiotics, and use a 200μL pipette tip to streak from the spot to isolate a single bacterium.
[0058] 6) The clones on the plates of step 4) and step 5) were verified for copy number by colony PCR to obtain edited E. coli strains containing genes with different copy numbers on the chromosome.
[0059] Preferably, the target clone can also be subjected to plasmid elimination using pCutamp to obtain a plasmid-free E. coli editing strain, comprising the following steps:
[0060] 1) Prepare the above target clone into electrocompetent cells, electrotransform the plasmid pCutamp, and resuscitate at 37°C for 40 min. Transfer the resuscitated bacterial solution to a test tube containing 3 mL of LB liquid medium, add apramycin and 10 mM rhamnose, and continue to culture at 37°C for 3 h. Collect 0.5 mL of the bacterial solution and spread it on an LB solid plate containing apramycin and 10 mM rhamnose, and continue to culture at 37°C overnight.
[0061] 2) The positive clones obtained on the plate in step 1) were spotted onto single antibiotic LB solid plates containing ampicillin, kanamycin and streptomycin, and were also spotted onto LB solid plates containing 10 g / L sucrose to screen out the plasmid pCutamp itself.
[0062] 3) Select the clones that cannot grow on the single antibiotic LB solid plate of ampicillin, kanamycin and streptomycin in step 2) but grow on the sucrose plate, spot them on the apramycin plate, verify the elimination of the pCutamp plasmid, and obtain the edited strains that have eliminated all plasmids.
[0063] Considering the convenience of experimental operation, the MUCICAT system of the present invention can be a kit, and the required materials are concentrated in one kit. In a preferred embodiment, the above-mentioned kit, in addition to plasmids, various PCR primers for implementing genome editing, etc., can also include at least one of the following items: a carrying tool, whose space is divided into a limited space that can accommodate one or more containers, 96-well plates or strips, such as a kit, a medicine bottle, a test tube, and the like, each of which contains a separate component for the method of the present invention; instructions, which can be written on bottles, test tubes and the like, or on a separate piece of paper, or on the outside or inside of a container, such as a paper with an operation demonstration video APP download window such as a QR code, and the instructions can also be in the form of multimedia, such as a CD, a U disk, a network disk, etc.
[0064] The present invention will be further described below in conjunction with specific embodiments. It should be understood that these embodiments are only for illustrative purposes and are not intended to limit the present invention. In addition, it should be understood that after reading the concept of the present invention, various changes or adjustments made by those skilled in the art should fall within the scope of protection of the present invention, and these equivalent forms also belong to the scope limited by the appended claims of the present application.
[0065] This article involves the addition amount, content and concentration of various substances, and the percentages mentioned here refer to the mass percentages unless otherwise specified.
[0066] Example
[0067] Materials and methods
[0068] The whole gene synthesis, primer synthesis and sequencing in the examples were all completed by Nanjing GenScript Biotechnology Co., Ltd.
[0069] The molecular biology experiments herein include plasmid construction, restriction digestion, ligation, competent cell preparation, transformation, culture medium preparation, etc., and are mainly carried out with reference to "A Guide to Molecular Cloning" (3rd edition), compiled by J. Sambrook and DW Russell (USA), translated by Huang Peitang, etc., Science Press, Beijing, 2002). If necessary, the specific experimental conditions can be determined by simple experiments. PCR amplification experiments are carried out according to the reaction conditions or instructions provided by the plasmid or DNA template supplier. If necessary, they can be adjusted by simple experiments.
[0070] PCR amplification experiments were performed according to the reaction conditions or instructions provided by the plasmid or DNA template supplier. If necessary, adjustments could be made through simple experiments.
[0071] Example 1 Targeting the IS1 or IS186 sequence of the Escherichia coli chromosome to achieve multi-copy integration of the target gene
[0072] The primers required for constructing pQCascade-IS1 and pQCascade-IS186 plasmids and PCR verification are shown in Table 1 .
[0073] Table 1. PCR primer sequences
[0074]
[0075]
[0076] Note: The suffix F in the primer name in the table represents the forward primer, and R represents the reverse primer.
[0077] 1.1 Obtain pQCascade backbone fragments by restriction digestion
[0078] The pQCascade_entry (synthesized by Nanjing GenScript Co., Ltd. based on the sequence of Addgene#130635) plasmid was digested with BsaI restriction endonuclease to obtain the pQCascade_entry backbone fragment.
[0079]
[0080] Reaction conditions: 37°C, 1 h. Separate the plasmid fragments after enzyme digestion by gel electrophoresis and recover them from the gel.
[0081] The restriction endonuclease kit was purchased from Fermentas, and the DNA gel recovery kit was purchased from Axygen.
[0082] 1.2 Primer annealing
[0083] The primer pairs in Table 1 can be annealed and self-assembled to obtain a spacer fragment containing a 4 bp sticky end, which is complementary to the sticky end of the pQCascade plasmid backbone after BsaI digestion.
[0084]
[0085] Keep warm at 95℃ for 5 min, decrease 5-10℃ per minute, keep warm at 16℃ for 10 min, dilute 20 times with ddH2O and set aside.
[0086] 1.3 Ligation construction of plasmid pQCascade-IS1 or pQCascade-IS186
[0087]
[0088] Ligation was carried out at 16°C for 1 h. T4 ligase kit was purchased from TAKARA.
[0089] All the above ligation products were transformed into DH5α competent cells (purchased from Shenzhen Kangti Life Science Co., Ltd.), and screened on LB solid plates containing streptomycin to obtain plasmid pQCascade-IS1 or pQCascade-IS186. The QCas750R primer was used for sequencing to verify the correctness.
[0090] 1.4 Transformation of transposition tool plasmid and induced transposition
[0091] pDonor (synthesized by Nanjing GenScript according to the sequence of Addgene#130634) and pTnsABC (synthesized by Nanjing GenScript according to the sequence of Addgene#130633) were electrotransformed into E. coli BL21 (DE3), and screened on LB solid plates containing ampicillin and kanamycin at 37°C. Positive clones were selected and prepared into electrotransformation competent cells, and then pQCascade-IS1 or pQCascade-IS186 was electrotransformed into the above bacteria, and screened on LB solid plates containing ampicillin, kanamycin and streptomycin at 37°C to obtain E. coli BL21 (DE3) strains containing three plasmids: pDonor, pTnsABC and pQCascade-IS1 or pQCascade-IS186. Scrape a portion of the clones on the plate and resuspend them in liquid LB medium. Re-spread them on a solid LB plate containing a final concentration of 0.1 mM IPTG, ampicillin, kanamycin and streptomycin. IPTG is responsible for inducing the expression of transposition-related enzymes. Cultivate at 37°C for 16 hours. A layer of bacterial film may form, which is normal. Scrape a portion of the clones on the plate containing 0.1 mM IPTG and resuspend them in liquid LB medium. Adjust the OD 600 After the concentration reached about 0.5, the plate was diluted 50 times with liquid LB medium, and 100 μL was spread on a solid LB plate supplemented with IPTG, ampicillin, kanamycin and streptomycin at a final concentration of 1 mM, and cultured at 37°C for 24 h.
[0092] In order to increase the number of inserted copies, you can choose to extend the transposition time by subculture. Randomly select the clones on the plate containing 1mM IPTG inducer, dip the clones with a 10μL pipette tip, and spot them on a new LB solid plate containing 1mM IPTG and the above three antibiotics. Use a 200μL pipette tip to streak from the spot to isolate a single bacterium, and culture it at 37℃ for 24h. The newly grown colonies on the plate are the second generation colonies. Using the newly grown colonies as the starting colonies, repeat the above operation to obtain the third, fourth, and nth generation colonies.
[0093] 1.5 Colony PCR to identify the copy number of IS186
[0094] The insertion of the five IS186 sites in the genome cloned on the first generation plate targeting IS186 was verified by colony PCR using the primer pairs IS186-F / 1R to IS186-F / 5R located approximately 300 bp upstream and downstream of the insertion site in Table 1.
[0095]
[0096]
[0097] PCR Mix was purchased from Novezan.
[0098] PCR reaction conditions:
[0099]
[0100] The donor insert fragments on the plasmid pDonor include LE (Left End), RE (Right End) and CmR fragment (chloramphenicol resistance gene fragment without promoter), totaling 983bp, with a positive band of about 1600bp and a negative band of about 600bp. According to statistics, 11 of the 14 clones had insertions in all five IS186 sites of the genome, that is, 5 copies were inserted, 1 clone had 4 copies inserted, and 2 clones had 3 copies inserted. Some gel electrophoresis images are shown in Figure 2. Figure 1 shown.
[0101] The above results show that the MUCICAT system can be used to target the IS186 site with 5 copies of the genome, and the insertion of 5 copies of the genome can be achieved in one transposition, with a total insertion rate of 100% and a 5-copy insertion rate of 78.57%. It only takes 5 days to insert 5 copies of the target gene into the genome using the MUCICAT system, which has the advantages of simple operation, short time and high efficiency.
[0102] 1.6 Identification of the copy number of targeted IS1 by quantitative PCR
[0103] Since there are 28 copies of the insertion sequence IS1 site on the E. coli BL21 (DE3) genome, it is time-consuming and laborious to use colony PCR for site verification, so the copy number verification was performed by fluorescent quantitative PCR (qPCR). 11 clones on the 1mMIPTG plate were randomly selected and inoculated into 3mL liquid LB medium and cultured overnight at 37°C and 200rpm. 0.5mL of bacteria were collected by centrifugation and the genome was extracted. The bacterial genome kit was purchased from Axygen and the experimental operation was carried out according to the instructions.
[0104] The sequence of the target gene inserted into the IS1 site in the RE-CmR-LE direction was used as a reference to design a specific qPCR primer pair qIS1-F / R (see Table 1). At the same time, gapA was selected as the internal reference gene and the internal reference primer pair gapA-F / R (Table 1) was designed. The extracted genome was used as a template for qPCR verification. qPCR system (20μL):
[0105]
[0106] qPCR reaction conditions:
[0107]
[0108] The qPCR kit SYBR Green Supermix was purchased from BioRad.
[0109] To reduce the impact of errors, three parallel groups were set for each sample. The obtained qPCR data were processed by the Pfaffl method to calculate the corresponding copy numbers of different clones.
[0110] By detecting the insertion copy number of each strain during the transposition process, the following results were obtained: Figure 2 The bar graph curve shown is composed of Figure 2 It can be seen that as the transposition time increases during the subculture process, the copy number of the strain genome insertion shows an overall upward trend.
[0111] About 300 bp upstream of the 28 insertion sites, 28 forward primers were designed, and reverse primers were designed in the RE-CmR-LE direction and LE-CmR-RE direction, forming 56 primer pairs, which can be used to specifically identify the true insertion of the IS1 site by colony PCR. The strain IS1Cm-16A with the highest number of insertion copies in the 8th generation was selected and streaked on an LB solid plate containing 10 g / L glucose. The grown single bacteria were used as templates for colony PCR identification. The identification results are as follows: Figure 3 shown.
[0112] The above results show that Escherichia coli BL21 (DE3) targeted the IS1 site containing 28 copies for transposition. After 8 subcultures, a strain with 16 copies of the target gene inserted into the genome can be obtained.
[0113] Example 2 Using array to target 8 different sites on the Escherichia coli chromosome to achieve multi-copy integration of the target gene
[0114] 2.1 Construction of plasmid pQCascade-array1
[0115] The crRNAs targeting 8 different sites of the E. coli BL21 (DE3) genome were combined to form an array sequence consisting of 9 fixed direct repeat sequences and 8 spacers targeting different sites, which were inserted between two BsaI sites of the pQCascade_entry plasmid to construct the plasmid pQCascade-array1. The array sequence synthesis and the above plasmid construction were completed by Nanjing GenScript Co., Ltd.
[0116] 2.2 Transposition tool plasmid and induced transposition
[0117] The three plasmids pDonor, pTnsABC and pQCascade-array1 were electroporated into E. coli BL21 (DE3) and the transformation operation was the same as step 1.5. The plate colony induction transposition and subculture operation were the same as step 1.5.
[0118] 2.3 Colony PCR identification of 8 genomic loci insertion
[0119] Forward and reverse primers were designed about 300 bp upstream and downstream of the 8 genomic sites, i.e., the primers required for verification. The sequences are shown in Table 2.
[0120] Table 2. 8-site verification primer sequences
[0121] Primers Sequence (5'→3') cr1-UF CAACTGGTCACGCTGATCG cr1-DR CTGTTCAACCTGGTCCAGCC cr2-UF GCCATGCTAACTCGTCCAAAC cr2-DR GCGTATGAAGAGCGGTGAGC 3U GTGGAATTACTGGCAGCGAC cr3DR CGGTGGTATATTCCCTTCTGATG 4U CTGCATGTACGTGCCTTCC cr4DR GCTACCGAAGGGACTATTCCTC cr5-UF CAGAGATGGAAATTACCCTGCAAG cr5-DR CGTTTGCCGTTCAACAACG 6U GGTGCAAGTATCATCACCACTTC 6DJ GTCGATTACGAGACGTTGATGAAG 7U CTGGTATCGTAAAATGGTTCAACG 7DJ CCATGTCCTGACCTGGGTTC 8U TCTTCCGCATTACCCTGGTG d8D TACACTGAACTCTCTGGCTCAC
[0122] Note: The suffix F in the primer name in the table represents the forward primer, and R represents the reverse primer.
[0123] The PCR system and reaction conditions were the same as in step 1.6.
[0124] The insertion of each clone at the 8 genomic sites was verified by colony PCR and nucleic acid gel electrophoresis. Figure 4 As shown, the number of insertions at the 8 sites of the target colony increased iteratively with the passage.
[0125] By counting the number of inserted copies of the 8 genomic loci of each colony during the subculture process, we can obtain the following Figure 5 The bar graph shows the changes in the number of insertion sites at 8 sites in the genome during the subculture process. As the subculture time increases, the number of inserted copies of the target gene in the genome increases significantly as a whole, and the proportion of high-copy strains also shows an increasing trend.
[0126] Example 3 Targeting 8 different sites of the BL21 (DE3) genome to construct a GDH production strain
[0127] Glucose dehydrogenase (GDH) (EC: 1.1.1.47) is an important biocatalytic enzyme for NAD(P)H regeneration, and is currently produced in China using the pET system. We replaced the target gene cargo on pDonor with the T7-GDH expression cassette to obtain engineered bacteria with integrated serial copy numbers, and compared the expression effect with that of pET24a to explore whether the MUCICAT system can be used to transform a GDH industrial strain with better expression than pET24a.
[0128] Table 3. Primers required for construction and verification of pDonor-GDH plasmid
[0129] Primers Sequence (5'→3') GDH-F TTTCATGAAGAGGTCATTTCCGGGGATCCGGCGTAGAGGATCGAGATC GDH-R AGCAAAACTACTGCAGTAAGGACTCTAGAATCCGGATATAGTTCCTCCT Donor-350F CAGCAACTTAACCACAAAACAAC Donor-200R CCAATATGGACAACTTCTTCGC
[0130] Note: The suffix F in the primer name in the table represents the forward primer, and R represents the reverse primer.
[0131] 3.1 Enzyme digestion of plasmid pDonor
[0132] The plasmid pDonor was double-digested with BamHI and XbaI restriction endonucleases. The digestion reaction system (50 μL) was as follows:
[0133]
[0134] Reaction conditions for enzyme digestion: 37°C, 1 h. The plasmid fragments after enzyme digestion were separated by gel electrophoresis and recovered from the gel to obtain the pDonor backbone fragment.
[0135] 3.2 PCR T7-GDH fragment
[0136] Using the primer pair GDH-F / R in Table 3 and pET-GDH as a template, PCR was performed to obtain the T7-GDH fragment connected to the pDonor backbone after restriction digestion.
[0137]
[0138] Prime Star Mix kit was purchased from TAKARA.
[0139] PCR reaction conditions:
[0140]
[0141] The PCR product was separated by gel electrophoresis and the plasmid fragments after restriction digestion were recovered from the gel to obtain the T7-GDH fragment.
[0142] The pDonor backbone was ligated with the T7-GDH fragment after restriction digestion.
[0143] 3.3 Ligation and construction of plasmid pDonor-GDH
[0144]
[0145] After incubation at 50°C for 30 min, all ligation products were transformed into DH5α competent cells and screened on LB solid plates containing ampicillin to obtain plasmid pDonor-GDH. Sequencing with Donor350R and Donor200F primers verified that the plasmid was correct. The recombination ligation kit was purchased from Novezan.
[0146] 3.4 Transposition tool plasmid and induced transposition
[0147] Transform pDonor-GDH, pTnsABC and pQCascade-array1 into E. coli BL21 (DE3), induce the expression of transposition-related enzymes with IPTG, and follow the same steps as 1.4. To increase the number of inserted copies of the target gene in the genome, perform appropriate subculture to extend the transposition time, and follow the same steps as 1.4.
[0148] 3.5 Colony PCR to identify the insertion of target gene
[0149] Select the clones on the plate containing 1mM IPTG inducer for colony PCR identification to determine the inserted copy number of the T7-GDH gene expression cassette. The verification primers used for colony PCR are shown in Table 2, and the reaction system and conditions are the same as step 1.6.
[0150] 3.6 Plasmid elimination
[0151] In order to obtain the strain with the best expression level and enzyme activity, that is, to obtain the optimal copy number of the T7-GDH gene expression cassette, we need to remove the plasmid from the strains with different copy numbers of the T7-GDH gene expression cassette to eliminate the interference of the T7-GDH gene expression cassette on the pDonor plasmid, stop transposition, and maintain strain stability. We replaced the sgRNA of the plasmid pEcCas constructed in our laboratory (see Chinese patent application CN201911291240.0, which contains the cas9 nuclease gene, the λ-RED recombinase gene, the araC protein gene, the sacB gene, the replicon pSC101, the rhamnose regulatory protein RhaS / RhaR gene, and the sgRNA sequence for directing Cas9 to the auxiliary plasmid DNA sequence) with the consensus sequence targeting the AmpR promoter on the pDonor, pTnsABC and pQCascade plasmid backbones, the consensus sequence is shown in sequence 5 (5'-TATTATTGAAGCATTTATCAGGG-3', SEQ ID NO: 5), and constructed the plasmid pCutamp to eliminate the transposition tool plasmid. The map of the plasmid pCutamp is shown in Figure 6 The plasmid pCutamp contains the cas9 gene, sacB gene, and sgRNA.
[0152] Specific plasmid elimination steps:
[0153] 1) Prepare the above target clone into electrocompetent cells, electrotransform the plasmid pCutamp, and resuscitate at 37°C for 40 min. Transfer the resuscitated bacterial solution to a test tube containing 3 mL of LB liquid medium, add apramycin and 10 mM rhamnose, and continue to culture at 37°C for 3 h. Collect 0.5 mL of the bacterial solution and spread it on an LB solid plate containing apramycin and 10 mM rhamnose, and continue to culture at 37°C overnight.
[0154] 2) The positive clones obtained on the plate in step 1) were spotted onto single antibiotic LB solid plates containing ampicillin, kanamycin and streptomycin, and were also spotted onto LB solid plates containing 10 g / L sucrose to screen out the plasmid pCutamp itself.
[0155] 3) Select the clones that cannot grow on the single antibiotic LB solid plate of ampicillin, kanamycin and streptomycin in step 2) but grow on the sucrose plate, spot the plate on the apramycin plate, verify the elimination of the pCutamp plasmid, and obtain the GDH production strain with all plasmids eliminated.
[0156] According to the above steps, the GDH expression cassette was targeted to 8 different sites in the genome and the strain was induced to eliminate the plasmid after three passages, and an enzyme expression strain library containing a series of T7-GDH expression cassette copies with a maximum copy number of 8 was obtained.
[0157] 3.7 Enzyme activity test of GDH production strain
[0158] The current common strategy for the production of GDH is to express it with pET series plasmids, so a strain containing pET24a-GDH plasmid is added as a control during the enzyme activity test. The shake flask fermentation steps are as follows: Escherichia coli BL21 (DE3) with multiple copies of T7-GDH gene expression cassette or pET24a-GDH is cultured in 3mL LB liquid medium at 37°C overnight. Then, 300μL of the above culture is inoculated into 30mL Terrific Broth (TB) medium in a 250mL shake flask. The cells are cultured at 37°C until OD 600 =2-4, at this time IPTG was added to a final concentration of 0.3 mM, and the fermentation was continued at 28°C for 40 hours.
[0159] To determine the enzyme activity of GDH, centrifuge at 1,500×g for 10 min at 4°C and collect 1 mL of the fermentation culture. Discard the supernatant culture and resuspend the cells with 1 mL of 100 mM Tris-HCl (pH 7.5). Ultrasonicate on ice to obtain the cell lysate, i.e., the crude enzyme solution. The ultrasonic conditions are: 200 W, 3 s working, 5 s interval, 40 times. The reaction mixture for the enzyme activity test contains 100 mM glucose, 100 mM Tris-HCl (pH 7.5), 2 mM NAD and the crude enzyme solution diluted 8000 times, and the reaction is carried out at 25°C. GDH will convert NAD + Converted into NADH, making OD 340 The absorbance increases. By recording the OD 340 The change in absorbance can be used to calculate the GDH enzyme activity by the following formula: U / mL = [ΔA / min] × [1 / ε] × 8000 (ε = A / cL = 6.402 mL / ( / mol*cm)).
[0160] like Figure 7 As shown in the figure, the strains with different copies of T7-GDH gene expression cassettes in the genome obtained by the MUCICAT system were compared with the strains expressed by traditional pET24a at the shake flask level for enzyme activity. The results showed that the strains with T7-GDH gene expression cassettes inserted at 3 to 6 sites in the genome had GDH enzyme activity significantly higher than that of the industrial pET24a expression strains. After 40 hours of shake flask fermentation, the enzyme activity of the best performing strain among the industrial pET24a expression strains was 160.95U / mL, but at this time, the enzyme activity of the GDH production strain inserted at 6 sites of the MUCICAT system had reached 460.76U / mL, which was 2.86 times that of the pET24a expression strain.
[0161] Example 4 Modification of the CAST system to target the IS1 sequence of the Escherichia coli chromosome to achieve multi-copy integration of the target gene
[0162] Table 4. Primers required for construction and verification of pSC101-Donor and pT7-Helper plasmids
[0163]
[0164]
[0165] Note: The suffix F in the primer name in the table represents the forward primer, and R represents the reverse primer.
[0166] 4.1 PCR plasmid pDonor_ShCAST_kanR backbone and pSC101 replicon
[0167] PCR was performed using the primer pairs 101-DonorF / R and pSC101-F / R in Table 4, with pDonor_ShCAST_kanR (purchased from Addgene #127924) and pKD46 plasmid (see Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci US A. 2000, 97(12):6640-5) as templates, respectively.
[0168]
[0169] Prime Star Mix kit was purchased from TAKARA.
[0170] PCR reaction conditions:
[0171]
[0172] The PCR products were separated by gel electrophoresis and recovered from the gel to obtain DNA fragments with about 20 bp overlapping sequences: pDonor_ShCAST_kanR plasmid fragment without replicon and pSC101 replicon fragment.
[0173] 4.2 Ligation construction of plasmid pSC101_Donor
[0174] The pDonor_ShCAST_kanR fragment without replicon (fragment 1) was ligated with the pSC101 replicon fragment (fragment 2). The recombination ligation kit was purchased from Novezan.
[0175] Ligation system (10 μL):
[0176] Ligation Mix 5 μL
[0177] Fragment 1 2.5 μL
[0178] Fragment 2 2.5 μL
[0179] After incubation at 50°C for 30 min, all ligation products were transformed into DH5α competent cells and screened on LB solid plates containing kanamycin to obtain plasmid pSC101_Donor. Sequencing with DonorRE-F primers verified that the plasmid replicon was correctly replaced with pSC101.
[0180] 4.3 Construction of plasmid pT7_Helper
[0181] Using the primer pairs T7-HelperF / R and Helper-T7F / R in Table 4, PCR was performed with pHelper-ShCAST-sgRNA (abbreviated as pHelper, purchased from Addgene#127921) and pQCascade_entry plasmid as templates to obtain pHelper plasmid fragment (fragment 1) and T7-lacI fragment (fragment 2). The PCR reaction system and reaction conditions were the same as 4.1.
[0182] The two fragments were connected, and the connection system was the same as 4.2. After incubation at 50°C for 30 minutes, all the connection products were transformed into DH5α competent cells and screened on LB solid plates containing ampicillin to obtain plasmid pT7_Helper. The plasmid was verified to be correct by sequencing with pBR322ori-F primer.
[0183] 4.4 Obtaining pT7_Helper plasmid fragment by restriction digestion
[0184] The pT7_Helper plasmid was digested with LguI restriction endonuclease to obtain the pT7_Helper plasmid fragment.
[0185]
[0186] Reaction conditions: 37°C, 1 h. The plasmid fragments after enzyme digestion were separated by gel electrophoresis and recovered from the gel. The restriction endonuclease kit was purchased from Fermentas, and the DNA gel recovery kit was purchased from Axygen.
[0187] 4.5 Primer annealing
[0188] The primer pair CASTIS1-F / R in Table 4 can be annealed and self-assembled to obtain a spacer fragment containing a 4 bp sticky end, which is complementary to the sticky end of the pT7_Helper plasmid backbone after LguI digestion.
[0189]
[0190] Keep warm at 95℃ for 5 min, decrease 5-10℃ per minute, keep warm at 16℃ for 10 min, dilute 20 times with ddH2O and set aside.
[0191] 4.6 Ligation construction of plasmid pT7_Helper_IS1
[0192]
[0193] Ligation was carried out at 16°C for 1 h. T4 ligase kit was purchased from TAKARA.
[0194] All the above ligation products were transformed into DH5α competent cells (purchased from Shenzhen Kangti Life Science Co., Ltd.), screened on LB solid plates containing ampicillin, and obtained plasmid pT7_Helper_IS1. The plasmid was sequenced with Amp-R primer to verify its correctness.
[0195] 4.7 Transposition tool plasmid and induced transposition
[0196] Electrotransform pSC101-Donor and pT7-Helper_IS1 into E. coli BL21 (DE3), screen on LB solid plates containing ampicillin and kanamycin at 30°C, and grow overnight. Scrape a portion of the clones on the above plate and resuspend them in liquid LB medium, and re-spread them on LB solid plates containing a final concentration of 0.1mM IPTG, ampicillin and kanamycin. IPTG induces the expression of transposition-related enzymes. Cultivate at 30°C for 16 hours. A layer of bacterial film may form, which is normal. Scrape a portion of the clones on the above plate containing 0.1mM IPTG and resuspend them in liquid LB medium, adjust the OD600 After the concentration reached about 0.5, the plate was diluted 50 times with liquid LB medium, and 100 μL was spread on a solid LB plate supplemented with IPTG, ampicillin and kanamycin at a final concentration of 1 mM, and cultured at 30°C for 24 h.
[0197] In order to increase the number of inserted copies, you can choose to extend the transposition time by subculture. Randomly select the clones on the plate containing 1mM IPTG inducer, dip the clones with a 10μL pipette tip, and spot them on a new LB solid plate containing 1mM IPTG and the above three antibiotics. Use a 200μL pipette tip to streak from the spot to isolate a single bacterium, and culture it at 30℃ for 24h. The newly grown colonies on the plate are the second generation colonies. Using the newly grown colonies as the starting colonies, repeat the above operation to obtain the third, fourth, and nth generation colonies.
[0198] 4.8 Colony PCR to identify the copy number of targeted IS1
[0199] Using the sequence of the target gene inserted into the IS1 site in the LE-KanR-RE direction as a reference, 29 specific PCR primer pairs, insBF / IS1-1R~insBF / IS1-30R and IS1-25F / R (see Table 4), were designed. The insertion of 29 IS1 sites in E. coli BL21 (DE3) was verified by colony PCR.
[0200] The donor insert fragments on the plasmid pSC101-Donor include LE (Left End), RE (Right End) and KanR fragments, totaling 2210bp, with a positive band of about 3000bp and a negative band of about 800bp. Some colonies were selected on the third generation plate for culture at 37°C and transferred into the pCutamp plasmid to eliminate the transposition plasmid. After isolating the single bacteria, colony PCR verification was performed, and two strains (i.e., strains No. 3 and No. 6) were successfully screened to achieve double copy insertion. The gel electrophoresis diagram is shown in the figure below. Figure 8 shown.
[0201] The above results verify that the MUCICAT system of the present invention can be used for multi-copy integration of bacterial genes and quickly and efficiently generate a strain library containing different copies of target genes.
[0202] It should also be noted that the listing and discussion of previously published documents in this specification should not be regarded as an admission that the document is prior art or common knowledge. Sequence Listing <110> Shanghai Institutes for Life Sciences, Chinese Academy of Sciences <120> A method for rapid multi-copy integration of target genes in bacterial chromosomes <130> SHPI2010020 <160> 5 <170> SIPO Sequence Listing 1.0 <210> 1 <211> 32 <212> DNA <213> Artificial Sequence () <400> 1 tggatgcttt gcgtgcaaag gaacctgaac tc 32 <210> 2 <211> 32 <212> DNA <213> Artificial Sequence () <400> 2 tggcacggct gggacggaag tcgctgtcgt tc 32 <210> 3 <211> 520 <212> DNA <213> Artificial Sequence () <400> 3 ccatgggtga actgccgagt aggtagctga taacgcctgg cttggcgatg ctcgcctgat 60 cgacaagtga actgccgagt aggtagctga taacgagaat attgtggcaa aagcgcataa 120 ggtgctgtga actgccgagt aggtagctga taacgtcaga gtggcgtatc cgatgaatca 180 ccacaggtga actgccgagt aggtagctga taacgcagaa gtgcacggcg tgtgcggcgg 240 cgagcagtga actgccgagt aggtagctga taactcgatc cgtgggtgtt tatgttctca 300 gcaggagtga actgccgagt aggtagctga taacttactt acggcgttgc gcattctcat 360 tgcaccgtga actgccgagt aggtagctga taacgcatta ctaagctggc gcgtgaagct gtagaagtga actgccgagt aggtagctga taacggggcg taaaaagaag gggcgctgat taacgcgtga actgccgagt aggtagctga taacggatcc <210> 4 <211> 24 <212> DNA <213> Container() <400> 4 ttttatgttc agataatgcc cgat <210> 5 <211> 23 <212> DNA <213> Container() <400> 5 tattattgaa gcatttatca ggg
Claims
1. A method for integrating a target gene into a bacterial chromosome in multiple copies, comprising the following steps: using a CRISPR-Cas related transposition system INTEGRATE system or CAST system to transform a crRNA sequence in a crRNA expression plasmid that targets a single genomic site, so that the transformed crRNA targets a multi-copy sequence or multiple sites in the bacterial chromosome, guides the target gene to be inserted into these sites, and achieves multi-copy insertion of the target gene on the bacterial chromosome, The modified crRNA targets multiple copy sequences in the genome; or forms two or more crRNA arrays that target different sites in the bacterial chromosome, wherein the modified crRNA is selected from: The crRNA targeting the IS186 sequence in the bacterial chromosome has a spacer sequence of SEQ ID NO:
1. A crRNA targeting the IS1 sequence in the bacterial chromosome, wherein the spacer sequence is SEQ ID NO: 2; or crRNA array, which is shown in SEQ ID NO:
3.
2. The method according to claim 1, characterized in that The transposition system INTEGRATE system comprises: a plasmid pQCascade, a plasmid pDonor containing a target gene, and a transposase expression vector pTnsABC, wherein the plasmid pQCascade contains a cas5678 nuclease gene and a tniQ transposase gene derived from Vibrio cholerae; The transposition system CAST system comprises: a CRISPR nuclease expression plasmid pHelper, and a plasmid pDonor containing a target gene, wherein the plasmid pHelper comprises a cas12k nuclease gene, a tnsBC transposase gene and a tniQ transposase gene derived from Bifidobacterium hallii.
3. The method according to claim 2, characterized in that The modified crRNA or crRNA array is cloned and expressed on plasmid pQCascade or pHelper; or expressed by a separate vector.
4. The method according to claim 3, characterized in that When the modified crRNA is expressed by pQCascade in the INTEGRATE system, the plasmid pQCascade, the plasmid pDonor, and the vector pTnsABC in the transposition system INTEGRATE system are transferred into bacterial competent cells and screened; or When the modified crRNA is expressed by pHelper in the CAST system, the plasmid pHelper and plasmid pDonor in the transposition system CAST system are transferred into bacterial competent cells and screened.
5. The method according to claim 4, characterized in that The screened strains were further subjected to plasmid elimination to obtain plasmid-free gene-edited strains.
6. The method according to claim 1, characterized in that The bacteria is Escherichia coli.
7. The method according to claim 6, characterized in that The Escherichia coli is K-12, B or W Escherichia coli.
8. The method according to claim 6, characterized in that The Escherichia coli is BL21(DE3) or MG1655(DE3).
9. A plasmid composition for implementing the method according to any one of claims 1 to 8, which is: A plasmid composition comprising the transposition system INTEGRATE system, comprising: Plasmid pQCascade, plasmid pDonor containing a target gene, and transposase expression vector pTnsABC, wherein the plasmid pQCascade contains the cas5678 nuclease gene from Vibrio cholerae, the tniQ transposase gene, and the modified crRNA; or A plasmid composition comprising a transposition system CAST system, comprising: a CRISPR nuclease expression plasmid pHelper, and a plasmid pDonor comprising a target gene, wherein the plasmid pHelper comprises a cas12k nuclease gene, a tnsBC transposase gene, a tniQ transposase gene and a modified crRNA derived from Bifidobacterium huxleyi; The modified crRNA is selected from any one of SEQ ID NOs: 1-3 or any combination thereof.
10. The plasmid composition according to claim 9, characterized in that The plasmid composition comprising the transposition system INTEGRATE system also comprises a plasmid pCutamp for eliminating plasmids pQCascade, pDonor and pTnsABC, wherein the plasmid pCutamp contains a cas9 gene, a sacB gene, and a crRNA targeting a common sequence of the three plasmids pQCascade, pDonor and pTnsABC, wherein the common sequence is shown in SEQ ID NO:
5.
11. The plasmid composition according to claim 9 or 10, characterized in that The plasmid pQCascade contains the cas5678 nuclease gene, tniQ gene transposase gene, modified crRNA, CloDF13 replicon, T7 promoter, lacI repressor protein gene and streptomycin resistance gene derived from Vibrio cholerae; the pHelper plasmid contains the cas12k nuclease gene, tnsBC transposase gene, tniQ transposase gene, modified crRNA, pBR322 replicon, J23119 constitutive promoter and ampicillin resistance gene derived from Bifidobacterium huxleyi.
12. A kit comprising the plasmid composition comprising the transposition system INTEGRATE system according to any one of claims 9 to 11, or / and a plasmid composition comprising the transposition system CAST system.
Citation Information
Cited By
Novel CRISPR related transposase
CN115369098A
